Trane Technologies’ Thermo King Will Deliver All-Electric, Zero-Emission Solutions for End-to-End Cold Chain by 2023
Thermo King, a brand of global climate innovator Trane Technologies (NYSE: TT), today announced that it will invest more than $100 million over the next three years to deliver a fully electric product in every segment of the cold chain by 2023.
The company’s all-electric portfolio, branded evolve™, will include electric refrigeration solutions for truck, trailer, rail, air and marine transport in the North America, Latin America and Europe, Middle East and Africa (EMEA) regions. The evolve portfolio aligns with customers’ goals to transition to more sustainable solutions for their fleets, and will help advance Trane Technologies’ 2030 Sustainability Commitments, including its Gigaton Challenge to reduce customer greenhouse gas emissions by 1 billion metric tons.
As new products are added to the evolve portfolio, electric solutions will be available in every cold chain segment in EMEA by 2023, and in the Americas by 2025.
“Bold solutions for a more sustainable world are core to our strategy. We continue to innovate to help reduce the carbon footprint of customer operations,” said Paul Camuti, chief technology and sustainability officer for Trane Technologies. “The evolve portfolio builds on our ongoing efforts to help customers reduce environmental impact and meet their sustainability goals as they transition fleets and stay ahead of future regulation.”
The global leader in temperature control solutions already offers fully electric products such as the E-200 for middle and last-mile delivery, and the TE-18 and Athenia™ all-electric HVAC units for public bus transit. Successfully launched in EMEA in 2020, the Advancer trailer unit is 30% more fuel efficient than the market average and can operate on a variety of power sources such as shore power, hybrid, holdover battery and axle generator. In the Americas region, the enhanced electric architecture on the connected Precedent™ trailer unit leverages shore power and will undergo field trials with customers later this year. These innovations will pave the way for all-electric zero-emission trailer refrigeration units in both regions.
“Our expertise in electrification has positioned Thermo King as a trusted partner to respected industry leaders such as Isuzu, Tesco, Mercedes-Benz and technology companies such as ELMS, Gatik and BPW who continue to find new ways to innovate the cold chain,” said Karin De Bondt, president for Thermo King Americas. “Through these strategic partnerships we are able to further our advancements of sustainable power solutions and electrified product offerings that meet customer, regulatory and environmental requirements in our industry and our world.”
Providing electric solutions for buildings, homes and refrigerated transportation is part of Trane Technologies’ overall approach to reducing carbon emissions in the industries it serves, meeting its Gigaton Challenge for a more sustainable future, and supporting net-zero cities.
*The Thermo King evolve™ portfolio will include fully electric products and hybrid products using an internal combustion engine for an emergency backup power source only.
About Thermo King
Thermo King – by Trane Technologies (NYSE: TT), a global climate innovator – is a worldwide leader in sustainable transport temperature control solutions. Thermo King has been providing transport temperature control solutions for a variety of applications, including trailers, truck bodies, buses, air, shipboard containers, and railway cars since 1938. For more information, visit www.thermoking.com or www.europe.thermoking.com.
About Trane Technologies
Trane Technologies is a global climate innovator. Through our strategic brands Trane and Thermo King, and our environmentally responsible portfolio of products and services, we bring efficient and sustainable climate solutions to buildings, homes, and transportation. Learn more at tranetechologies.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210830005123/en/
Contact information
Media:
Jennifer Regina, Trane Technologies
+1-630-390-8011
jennifer.regina@tranetechnologies.com
Investors:
Zachary Nagle, Trane Technologies
+1-704-990-3913
zachary.nagle@tranetechnologies.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Siemens Energy Consolidates its Forerunner Status With Fabasoft Approve Cross-plant Quality Management Software21.9.2021 15:03:00 CEST | Press release
Siemens Energy is using Fabasoft Approve as the process-driven quality management solution for its Power Transformer segment. The global rollout of Fabasoft Approve is scheduled for upwards of 3,000 users following the successful completion of pilot projects at the two largest transformer plants in Weiz (Austria) and Nuremberg (Germany). The challenge for Siemens Energy was to implement a cross-plant quality management tool in one network with 14 locations in eight countries and to digitally map its existing processes. Thanks to its wide range of customization options and high degree of usability, Fabasoft Approve made a convincing case in the multi-stage selection process and stood out as the high-performance platform of choice for computer-aided quality (CAQ) processes. The cloud-based solution offers comprehensive complaint management that can even be handled from a smartphone or tablet – for both in-house use and remote use at the customer’s site. Allocating the necessary immediate
Davos Alzheimer's Collaborative, World Economic Forum Announce Major Milestones in the Global Fight Against Alzheimer’s Disease21.9.2021 15:00:00 CEST | Press release
The Davos Alzheimer’s Collaborative (DAC) is a global multi-stakeholder partnership that is mobilizing the world against Alzheimer’s disease. DAC announced today it has nearly completed financing of its foundational phase and has launched several key initiatives to advance Alzheimer’s research, prevention and care to advance the fight against the disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005348/en/ A recent WHO report shows that Alzheimer’s and dementia impacted more than 55 million families worldwide and cost the global economy approximately US$1.3 trillion in 2019. This annual cost is expected to rise to $2.8 trillion by 2030, based on predicted increases in cases and the cost of care. By averaging these numbers to assume an approximate annual cost of $2 trillion through 2030, we estimate the disease will cost the global economy a cumulative $20 trillion over the next decade. Due to rapid gains in globa
Get Real Health Announces Further International Expansion to Bring Patient Engagement Tools Into The Netherlands21.9.2021 15:00:00 CEST | Press release
Get Real Health, a member of the CPSI (NASDAQ: CPSI) family of companies and a provider of comprehensive patient engagement tools, has expanded its international presence through an implementation in the region of Achterhoek, Netherlands, together with local partners MIJNPGO and WeDoTrust. This implementation is meant to support the region’s ambition to become the healthiest region in the Netherlands by 2030. To that end, the project will have timed implementations and deployments aimed at improving healthcare across all demographics. The Achterhoek solution is based on Get Real Health’s existing platform, and is customized for the region’s needs and called “MIJNPGO.” This customization effort includes ensuring compliance with Medmij, the technology standard across the Netherlands, which requires the secure exchange of data between care providers and patients. The initial pilot served a select cohort of care organizations including Sensire, the largest elderly care organization in the
Planview Introduces TeamTap, New Team-Level Innovation and Ideation Capability21.9.2021 15:00:00 CEST | Press release
Planview, a global leader in Portfolio Management and Work Management solutions, today introduced TeamTap – a new innovation and ideation capability for Planview Spigit, Planview’s innovation management software. Created to help accelerate an organization’s transformation efforts, this new capability allows companies to drive employee engagement, deliver value, and foster a culture of innovation within a single application. TeamTap offers a lean approach to innovation, supporting and aligning to Agile ways of working. “More so than typical enterprise innovation models, TeamTap promotes collaboration and ideation within teams, using their crowd to lean in and problem solve,” said Louise Allen, Chief Product Officer, Planview. “TeamTap enables team-focused innovation and empowers employees throughout an organization to voice opinions and play an active role in creative ideation, helping their companies uncover ideas, challenges and opportunities that exist within their team and operation
Kymeta Announces Grant of New U.S. Patent for Multi-Beam Capabilities Enabling Simultaneous Multi-Orbit Connectivity21.9.2021 15:00:00 CEST | Press release
Kymeta (www.kymetacorp.com), the communications company making mobile global, announced today that the United States Patent and Trademark Office awarded Kymeta Corporation a U.S. Patent for its multi-beam antenna configuration, enabling redundant, simultaneous, multi-orbit satellite connectivity. Kymeta’s innovative patented technology can generate two beams simultaneously with a single antenna panel, enabling the tracking of two satellites across multiple constellations and seamless traffic hand off from the initial satellite to the second. Kymeta’s metamaterials approach forms, receives, and transmits multiple distinct beams, each with its own receive/transmit (RX/TX) connection, for redundant connectivity and intelligent data management. “Kymeta remains focused on adding relevant IP to our extensive patent portfolio and technology roadmap,” said Ryan Stevenson, Ph.D., Vice President and Chief Scientist at Kymeta. “Our advanced technology will offer capabilities that are critical to
Zynga’s Magical Match-3 Mobile Game, Harry Potter: Puzzles & Spells, Celebrates One-Year Anniversary21.9.2021 15:00:00 CEST | Press release
Today, Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, announced that its magical Match-3 mobile game, Harry Potter: Puzzles & Spells, is marking its one-year anniversary with a full week of festivities. Kicking off today, fans around the world are invited to join the celebration with a seven-day slate of in-game gifts, events, sweepstakes and new content commemorating the occasion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005079/en/ Zynga’s Magical Match-3 Mobile Game, Harry Potter: Puzzles & Spells, Celebrates One-Year Anniversary (Graphic: Business Wire) Since its launch in September 2020, Harry Potter: Puzzles & Spells has delighted fans with its authentic wizarding world puzzles and gameplay. With more than 2,000 puzzle levels in the main player journey, the game continues to invite players together to revel in the fun and excitement of Hogwarts with new content and events. Spotlight
Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches21.9.2021 14:00:00 CEST | Press release
Boehringer Ingelheim today announced the acquisition of Abexxa Biologics Inc., a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology research to develop the next generation of precision medicines designed to revolutionize cancer treatments. The acquisition will allow Boehringer Ingelheim to access Abexxa’s expertise in targeting cancer-specific proteins that are located inside the cell, rather than those expressed on the cell membrane. This enlarges the pool of potential cancer antigen targets. In particular, Abexxa’s technology could lead to the development of cancer immunotherapies that are effective in a broader range of patients and cancer types. “The acquisition of Abexxa bolsters our commitment to tumor-antigen discovery and new ways of targeting intracellular antigens. Their cutting-edge know-how and technologies for antigen discovery and novel antibody generation strongly complement the current approaches we have been applying successfu